PACS Group (NYSE:PACS) Earns Buy Rating from Analysts at Citigroup

Investment analysts at Citigroup started coverage on shares of PACS Group (NYSE:PACSGet Free Report) in a research note issued on Monday, MarketBeat.com reports. The firm set a “buy” rating and a $32.00 price target on the stock. Citigroup’s price objective would indicate a potential upside of 28.05% from the stock’s current price.

A number of other research analysts have also recently issued reports on PACS. Truist Financial began coverage on PACS Group in a research note on Monday. They set a “buy” rating and a $32.00 price objective for the company. Royal Bank of Canada initiated coverage on PACS Group in a research note on Monday. They set an “outperform” rating and a $30.00 price objective for the company. Finally, Oppenheimer initiated coverage on PACS Group in a report on Monday. They issued an “outperform” rating and a $31.00 target price for the company. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $30.50.

Read Our Latest Report on PACS

PACS Group Stock Up 0.2 %

Shares of NYSE:PACS opened at $24.99 on Monday. PACS Group has a 12-month low of $22.61 and a 12-month high of $25.72.

Insiders Place Their Bets

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of PACS Group stock in a transaction on Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the sale, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

About PACS Group

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

See Also

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.